Literature DB >> 1800987

Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism.

D K Kalousek1, P N Howard-Peebles, S B Olson, I J Barrett, A Dorfmann, S H Black, J D Schulman, R D Wilson.   

Abstract

About 2 per cent of specimens from chorionic villus sampling (CVS) analysed either on direct preparation of cytotrophoblast cells or after culture of mesenchymal stroma reveal confined placental mosaicism (CPM), most commonly involving chromosomal trisomy. A significantly higher rate of prenatal loss (22 per cent) as well as the presence of intrauterine growth retardation (IUGR) has been reported among pregnancies with CPM. To evaluate more precisely the effect of these aneuploid cell lines confined to the placenta on intrauterine fetal growth and fetal survival, we have studied 34 term placentae from pregnancies with CPM diagnosed on CVS and confirmed identical mosaicism in 17 of these placentae. There was a direct correlation between a high number of aneuploid cells present at CVS and a high likelihood of their detection in term placenta. Also, the proportion of aneuploid cells in the mosaic term placentae correlated with that observed in CVS specimens. Among 17 gestations with confirmed CPM at delivery, there were six cases of IUGR identified, five in liveborns and one associated with intrauterine death.

Entities:  

Mesh:

Year:  1991        PMID: 1800987     DOI: 10.1002/pd.1970111002

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  28 in total

Review 1.  Confined placental mosaicism and intrauterine fetal growth.

Authors:  V S Lestou; D K Kalousek
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  Spontaneous abortion and confined chromosomal mosaicism.

Authors:  D K Kalousek; I J Barrett; A B Gärtner
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Uniparental disomy 15 resulting from "correction" of an initial trisomy 15.

Authors:  S G Purvis-Smith; T Saville; S Manass; M Y Yip; P R Lam-Po-Tang; B Duffy; H Johnston; D Leigh; B McDonald
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffective.

Authors:  C B Coulam; R S Jeyendran; M Fiddler; E Pergament
Journal:  J Assist Reprod Genet       Date:  2007-01-11       Impact factor: 3.412

5.  Distribution of mosaicism in human placentae.

Authors:  K G Henderson; T E Shaw; I J Barrett; A H Telenius; R D Wilson; D K Kalousek
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

6.  Chromosomal mosaicism in mouse two-cell embryos after paternal exposure to acrylamide.

Authors:  Francesco Marchetti; Jack Bishop; Xiu Lowe; Andrew J Wyrobek
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

7.  Maternal origin of 47,XXY and confined placental mosaicism 47,XXY/48,XXY,+13 in an infant conceived through IVF.

Authors:  Elizabeth X Wu; Andrew D Wilson; Edgar Chan Wong; Jon C Havelock; Sai Ma
Journal:  J Assist Reprod Genet       Date:  2013-04-27       Impact factor: 3.412

8.  Meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction.

Authors:  W P Robinson; I J Barrett; L Bernard; A Telenius; F Bernasconi; R D Wilson; R G Best; P N Howard-Peebles; S Langlois; D K Kalousek
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

9.  Cytogenetic contribution to uniparental disomy (UPD).

Authors:  Thomas Liehr
Journal:  Mol Cytogenet       Date:  2010-03-29       Impact factor: 2.009

10.  Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol.

Authors:  D S Johnson; G Gemelos; J Baner; A Ryan; C Cinnioglu; M Banjevic; R Ross; M Alper; B Barrett; J Frederick; D Potter; B Behr; M Rabinowitz
Journal:  Hum Reprod       Date:  2010-01-24       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.